Cargando…

Quality of life in patients with hereditary haemorrhagic telangiectasia (HHT)

BACKGROUND: There are very few studies about general quality of life parameters, standards for the description of health status and comparison with general population data on patients with Hereditary hemorrhagic telangiectasia (HHT), a rare disease in which epistaxis is a cardinal symptom. PURPOSE:...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zarrabeitia, Roberto, Fariñas-Álvarez, Concepción, Santibáñez, Miguel, Señaris, Blanca, Fontalba, Ana, Botella, Luisa María, Parra, José Antonio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2017
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5259834/ https://www.ncbi.nlm.nih.gov/pubmed/28114930 http://dx.doi.org/10.1186/s12955-017-0586-z

Ejemplares similares

European Reference Network For Rare Vascular Diseases (VASCERN) Outcome Measures For Hereditary Haemorrhagic Telangiectasia (HHT)
por: Shovlin, Claire L., et al.
Publicado: (2018)

Hereditary Hemorrhagic Telangiectasia (HHT) and Survival: The Importance of Systematic Screening and Treatment in HHT Centers of Excellence
por: de Gussem, Els M., et al.
Publicado: (2020)

Mutation study of Spanish patients with Hereditary Hemorrhagic Telangiectasia
por: Fontalba, Ana, et al.
Publicado: (2008)

Development and validation of a quality of life measurement scale specific to hereditary hemorrhagic telangiectasia: the QoL-HHT
por: Le, Thi Thao Truc, et al.
Publicado: (2022)

Copy number variations in endoglin locus: mapping of large deletions in Spanish families with hereditary hemorrhagic telangiectasia type 1
por: Fontalba, Ana, et al.
Publicado: (2013)

Life expextancy of parents with Hereditary Haemorrhagic Telangiectasia
por: de Gussem, E. M., et al.
Publicado: (2016)

European Reference Network for Rare Vascular Diseases (VASCERN) position statement on cerebral screening in adults and children with hereditary haemorrhagic telangiectasia (HHT)
por: Eker, Omer F., et al.
Publicado: (2020)

Safety of thalidomide and bevacizumab in patients with hereditary hemorrhagic telangiectasia
por: Buscarini, Elisabetta, et al.
Publicado: (2019)

Antithrombotic Therapy in Hereditary Hemorrhagic Telangiectasia: Real-World Data from the Gemelli Hospital HHT Registry
por: Gaetani, Eleonora, et al.
Publicado: (2020)

A case report of hepatopulmonary syndrome in hereditary hemorrhagic telangiectasia (HHT): Not all right-to-left shunting in HHT is due to pulmonary arteriovenous malformations
por: Krishnan, Sheila, et al.
Publicado: (2018)

Intra-venous bevacizumab in hereditary hemorrhagic telangiectasia (HHT): A retrospective study of 46 patients
por: Guilhem, Alexandre, et al.
Publicado: (2017)

Prospective pilot study of Floseal® for the treatment of anterior epistaxis in patients with hereditary hemorrhagic telangiectasia (HHT)
por: Lee, John M., et al.
Publicado: (2019)

Fine mapping of the hereditary haemorrhagic telangiectasia (HHT)3 locus on chromosome 5 excludes VE-Cadherin-2, Sprouty4 and other interval genes
por: Govani, Fatima S, et al.
Publicado: (2010)

Hereditary Hæmorrhagic Telangiectasia with Recurring Hæmaturia
por: Foggie, W. E.
Publicado: (1928)

Screening for pulmonary and brain vascular malformations is the North American standard of care for patients with hereditary hemorrhagic telangiectasia (HHT): A survey of HHT Centers of Excellence
por: Kilian, Alexandra, et al.
Publicado: (2020)

Mutation affecting the proximal promoter of Endoglin as the origin of hereditary hemorrhagic telangiectasia type 1
por: Albiñana, Virginia, et al.
Publicado: (2017)

Systemic bevacizumab for high-output cardiac failure in hereditary hemorrhagic telangiectasia: an international survey of HHT centers
por: Al-Samkari, Hanny, et al.
Publicado: (2019)

Whole genome sequences discriminate hereditary hemorrhagic telangiectasia phenotypes by non-HHT deleterious DNA variation
por: Joyce, Katie E., et al.
Publicado: (2022)

Peliosis hepatis associated with hereditary haemorrhagic telangiectasia
por: Alessandrino, F., et al.
Publicado: (2013)

Hereditary Haemorrhagic Telangiectasia: With Report of a Case
por: McEwan, Tom
Publicado: (1948)

Pulmonary Arterial Hypertension and Hereditary Haemorrhagic Telangiectasia
por: Vorselaars, Veronique M. M., et al.
Publicado: (2018)

Pitfalls of delaying the diagnosis of hereditary haemorrhagic telangiectasia
por: Major, Tamás, et al.
Publicado: (2019)

Hereditary haemorrhagic telangiectasia: A case report
por: Mufti, Asfandyar, et al.
Publicado: (2021)

Impact of Pulmonary Arteriovenous Malformations on Respiratory–Related Quality of Life in Patients with Hereditary Haemorrhagic Telangiectasia
por: Blivet, Sandra, et al.
Publicado: (2014)

Hereditary haemorrhagic telangiectasia and pregnancy: a review of the literature
por: Dupuis, Olivier, et al.
Publicado: (2020)

Research on potential biomarkers in hereditary hemorrhagic telangiectasia
por: Botella, Luisa-María, et al.
Publicado: (2015)

Topical Propranolol Improves Epistaxis Control in Hereditary Hemorrhagic Telangiectasia (HHT): A Randomized Double-Blind Placebo-Controlled Trial
por: Mei-Zahav, Meir, et al.
Publicado: (2020)

Diode laser in the treatment of epistaxis in patients with hereditary haemorrhagic telangiectasia
por: FIORELLA, M.L., et al.
Publicado: (2012)

Altered hypoxia inducible factor regulation in hereditary haemorrhagic telangiectasia
por: Wrobeln, Anna, et al.
Publicado: (2022)

Life-threatening Anaemia in Patient with Hereditary Haemorrhagic Telangiectasia (Rendu-Osler-Weber Syndrome)
por: Mikołajczyk-Solińska, Melania, et al.
Publicado: (2020)

Endoplasmic Reticulum Quality Control Is Involved in the Mechanism of Endoglin-Mediated Hereditary Haemorrhagic Telangiectasia
por: Ali, Bassam R., et al.
Publicado: (2011)

Hereditary haemorrhagic telangiectasia: A disease not to be forgotten during the COVID‐19 pandemic
por: Gaetani, Eleonora, et al.
Publicado: (2020)

Endoglin involvement in integrin-mediated cell adhesion as a putative pathogenic mechanism in hereditary hemorrhagic telangiectasia type 1 (HHT1)
por: Rossi, Elisa, et al.
Publicado: (2015)

Sclerotherapy on Demand with Polidocanol to Treat HHT Nosebleeds
por: Marcos, Sol, et al.
Publicado: (2021)

Ocular lesions in hereditary hemorrhagic telangiectasia: genetics and clinical characteristics
por: Gómez-Acebo, Inés, et al.
Publicado: (2020)

Neurologic Manifestation as Initial Presentation in a Case of Hereditary Haemorrhagic Telangiectasia
por: Teo, Yeow Kwan, et al.
Publicado: (2010)

Long Non-Coding RNA Expression Profiles in Hereditary Haemorrhagic Telangiectasia
por: Tørring, Pernille M., et al.
Publicado: (2014)

Liver transplantation in a patient with hereditary haemorrhagic telangiectasia and pulmonary hypertension
por: Ejiri, Kentaro, et al.
Publicado: (2019)

Endoscopic surgical treatment of epistaxis in hereditary haemorrhagic telangiectasia: our experience
por: Pagella, Fabio, et al.
Publicado: (2021)

Pulmonary hypertension in hereditary haemorrhagic telangiectasia is associated with multiple clinical conditions
por: Margelidon-Cozzolino, Victor, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_4qi2q2544gu1afo4p56l61uj0m